183 related articles for article (PubMed ID: 32052315)
1. β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease.
Ikonomidis I; Katogiannis K; Kyriakou E; Taichert M; Katsimaglis G; Tsoumani M; Andreadou I; Maratou E; Lambadiari V; Kousathana F; Papadopoulou A; Varlamos C; Plotas P; Parissis J; Stamatelopoulos K; Alexopoulos D; Dimitriadis G; Tsantes AE
J Thromb Thrombolysis; 2020 Apr; 49(3):365-376. PubMed ID: 32052315
[TBL] [Abstract][Full Text] [Related]
2. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
[TBL] [Abstract][Full Text] [Related]
3. Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus.
Zhang D; Zhang X; Liu D; Liu T; Cai W; Yan C; Han Y
Cardiovasc Diabetol; 2016 Mar; 15():50. PubMed ID: 27005817
[TBL] [Abstract][Full Text] [Related]
4. Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study.
Gupta R; Kirtane AJ; Liu Y; Crowley A; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2019 Nov; 12(11):e007982. PubMed ID: 31672031
[TBL] [Abstract][Full Text] [Related]
5. Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel.
Xu K; Ye S; Zhang S; Yang M; Zhu T; Kong D; Chen J; Xu L; Li J; Zhu H; Wang F; Yang L; Zhang J; Fan Y; Ying L; Hu X; Zhang X; Chan NC; Li C
Circ Cardiovasc Interv; 2019 May; 12(5):e007019. PubMed ID: 31018667
[TBL] [Abstract][Full Text] [Related]
6. On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES.
Shahim B; Redfors B; Stuckey TD; Liu M; Zhou Z; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Srdanovic I; Madhavan MV; Mazzaferri EL; Mehran R; Ben-Yehuda O; Kirtane AJ; Stone GW
J Am Heart Assoc; 2023 Jan; 12(1):e026482. PubMed ID: 36565189
[TBL] [Abstract][Full Text] [Related]
7. High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers.
Marcucci R; Giusti B; Paniccia R; Gori AM; Saracini C; Valente S; Giglioli C; Parodi G; Antoniucci D; Gensini GF; Abbate R
Platelets; 2012; 23(8):586-93. PubMed ID: 22390861
[TBL] [Abstract][Full Text] [Related]
8. Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.
Christ G; Siller-Matula JM; Francesconi M; Dechant C; Grohs K; Podczeck-Schweighofer A
BMJ Open; 2014 Oct; 4(10):e005781. PubMed ID: 25361837
[TBL] [Abstract][Full Text] [Related]
9. Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin.
Siller-Matula JM; Delle-Karth G; Christ G; Neunteufl T; Maurer G; Huber K; Tolios A; Drucker C; Jilma B
Int J Cardiol; 2013 Jul; 167(2):430-5. PubMed ID: 22305813
[TBL] [Abstract][Full Text] [Related]
10. Posttreatment platelet reactivity on clopidogrel is associated with the risk of adverse events after off-pump coronary artery bypass.
Youn YN; Yi G; Lee S; Joo HC; Yoo KJ
Am Heart J; 2014 Jun; 167(6):818-25. PubMed ID: 24890530
[TBL] [Abstract][Full Text] [Related]
11. Individual long-term variation of platelet reactivity in patients with dual antiplatelet therapy after myocardial infarction.
Alfredsson J; Swahn E; Gustafsson KM; Janzon M; Jonasson L; Logander E; Nilsson L; Lindahl TL
Platelets; 2019; 30(5):572-578. PubMed ID: 29869923
[TBL] [Abstract][Full Text] [Related]
12. Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention.
Mangiacapra F; Bressi E; Colaiori I; Ricottini E; Cavallari I; Capuano M; Viscusi MM; Spoto S; Barbato E; Di Sciascio G
J Cardiovasc Transl Res; 2020 Aug; 13(4):668-675. PubMed ID: 31732918
[TBL] [Abstract][Full Text] [Related]
13. Reasons for the Failure of Platelet Function Testing to Adjust Antiplatelet Therapy: Pharmacodynamic Insights From the ARCTIC Study.
Lattuca B; Silvain J; Yan Y; Pouillot C; Cuisset T; Cayla G; Henry P; Diallo A; Elhadad S; Rangé G; Lhermusier T; Boueri Z; Motreff P; Carrié D; Vicaut E; Montalescot G; Collet JP
Circ Cardiovasc Interv; 2019 Nov; 12(11):e007749. PubMed ID: 31694410
[TBL] [Abstract][Full Text] [Related]
14. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.
Ueno M; Ferreiro JL; Desai B; Tomasello SD; Tello-Montoliu A; Capodanno D; Capranzano P; Kodali M; Dharmashankar K; Charlton RK; Bass TA; Angiolillo DJ
JACC Cardiovasc Interv; 2012 Mar; 5(3):293-300. PubMed ID: 22440495
[TBL] [Abstract][Full Text] [Related]
16. Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting.
Bouman HJ; Harmsze AM; van Werkum JW; Breet NJ; Bergmeijer TO; Ten Cate H; Hackeng CM; Deneer VH; Ten Berg JM
Heart; 2011 Aug; 97(15):1239-44. PubMed ID: 21628721
[TBL] [Abstract][Full Text] [Related]
17. High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study.
De Rosa R; Palmerini T; De Servi S; Belmonte M; Crimi G; Cornara S; Calabrò P; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Genereux P; Angiolillo D; Piscione F; Galasso G
Int J Cardiol; 2018 May; 259():20-25. PubMed ID: 29579602
[TBL] [Abstract][Full Text] [Related]
18. Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus.
Mangiacapra F; Peace A; Barbato E; Patti G; Gatto L; Ricottini E; De Bruyne B; Di Sciascio G; Wijns W
Platelets; 2014; 25(5):348-56. PubMed ID: 23971913
[TBL] [Abstract][Full Text] [Related]
19. On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty.
Grifoni E; Gori AM; Giusti B; Valenti R; Migliorini A; Basili S; Paniccia R; Elmahdy MF; Pulli R; Pratesi C; Antoniucci D; Violi F; Marcucci R
Eur J Vasc Endovasc Surg; 2018 Oct; 56(4):545-552. PubMed ID: 30025662
[TBL] [Abstract][Full Text] [Related]
20. Predictors of high on-clopidogrel platelet reactivity in patients with acute coronary syndrome.
Lee S; Hizoh I; Kovacs A; Horvath Z; Kiss N; Toth-Zsamboki E; Kiss RG
Platelets; 2016; 27(2):159-67. PubMed ID: 26247099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
